AGGRESSIVE LYMPHOMA
Clinical trials for AGGRESSIVE LYMPHOMA explained in plain language.
Never miss a new study
Get alerted when new AGGRESSIVE LYMPHOMA trials appear
Sign up with your email to follow new studies for AGGRESSIVE LYMPHOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New antibody therapy aims to keep lymphoma at bay after transplant
Disease control Recruiting nowThis early-phase study tests a drug called mosunetuzumab given after a stem cell transplant for people with aggressive B cell lymphomas that have come back or not responded to treatment. Mosunetuzumab is an engineered antibody that helps the body's immune T cells find and kill ca…
Matched conditions: AGGRESSIVE LYMPHOMA
Phase: PHASE1 • Sponsor: Washington University School of Medicine • Aim: Disease control
Last updated May 17, 2026 05:08 UTC
-
Can early palliative care boost quality of life for blood cancer patients?
Symptom relief Recruiting nowThis study looks at whether adding early palliative care to usual treatment helps people with multiple myeloma or aggressive lymphoma feel better. About 144 patients and their caregivers will either get early palliative care or standard care alone. Researchers will track quality …
Matched conditions: AGGRESSIVE LYMPHOMA
Phase: NA • Sponsor: University Health Network, Toronto • Aim: Symptom relief
Last updated May 17, 2026 05:06 UTC